Adjuvanted influenza vaccine vs non‐adjuvanted influenza vaccine: All‐cause mortality, allogeneic BMT
Adjuvanted influenza vaccine showed no clear difference in all‐cause mortality, allogeneic BMT, compared with non‐adjuvanted influenza vaccine (low certainty).
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Adjuvanted influenza vaccine vs non‐adjuvanted influenza vaccine All‐cause mortality, allogeneic BMT, · immunosuppressed adults with cancer Adjuvanted influenza vaccine showed no clear difference in all‐cause mortality, allogeneic BMT, compared with non‐adjuvanted influenza vaccine (low certainty). Influenza vaccines in immunosuppressed adults with cancer (2018) · Cochrane Headline outcomes only | RR 0.54 [0.05, 5.73] | 1 study · 73 participants | Low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Influenza vaccines in immunosuppressed adults with cancer 2018 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.